CHILDHOOD ANAPHYLAXIS: NEW DEVELOPMENTS IN DIAGNOSIS AND TREATMENT

CHILDHOOD_ANAPHYLAXIS_NEW_DEVELOPMENTS _IN_DIAGNOSIS_AND_TREATMENT_kapak

AVOIDANCE OF ALLERGENS AND TRIGGERS PROTECTION

Mehmet Şirin Kaya1 Ahmet Kan2

1Şanlıurfa Training and Research Hospital, Department of Pediatric Immunology and Allergic Diseases, Şanlıurfa, Türkiye
2Dicle University, Faculty of Medicine, Department of Pediatric Immunology and Allergic Diseases, Diyarbakır, Türkiye

Kaya MŞ, Kan A. Avoidance of Allergens and Triggers Protection. In: Harmancı K, editor. Childhood Anaphylaxis: New Developments in Diagnosis and Treatment. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.275-283.

ABSTRACT

Anaphylaxis is a sudden and potentially life-threatening systemic reaction. Acute interventions and long-term prevention strategies are vital in managing this serious condition. Identifying and avoiding specific allergens and non-immunological triggers in pediatric patients constitutes the basis of secondary prevention. In this section, current, practical, and evidence-based approaches to preventing and protecting against primary anaphylaxis triggers-such as foods, drugs, bee venom, latex, exercise, and pollen-are comprehensively reviewed. Avoidance strategies should be individualised according to the child’s sensitivity profile, clinical history, and environmental risk factors. Developing label-reading habits, preventing cross-contamination, implementing school and social safety measures, planning alternative medications, considering immunotherapy options, applying desensitisation protocols, and reducing environmental exposures are all essential elements in this context. Ensuring the accessibility of epinephrine auto-injectors, educating patients and caregivers, and establishing anaphylaxis action plans are all crucial steps in preventing potentially severe reactions. To improve the quality of life for children who have experienced anaphylaxis and to prevent recurrence, proper identification of risk factors, consistent application of avoidance strategies, and a multidisciplinary follow-up approach are necessary. With appropriate avoidance and protection measures, children with a history of anaphylaxis can lead safe and healthy lives.

Keywords: Anaphylaxis; Allergens and triggers; Allergen avoidance; Allergen protection; Epinephrine auto-injector

Referanslar

  1. Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-45. [Crossref]  [PubMed]
  2. Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-84. [Crossref]  [PubMed]
  3. Selmanoglu A, Haci IA, Koc FSM, Yildiz YK, Yilmaz EA, Azkur D, et al. Clinical and Treatment Evaluation of Anaphy laxis in Children Aged 0-2 Years: Multicenter Study. Pediatr Res. 2024;19. [Crossref]  [PubMed]
  4. Cianferoni A, Muraro A. Food-induced anaphylaxis. Immunol Allergy Clin North Am. 2012;32(1):165-95. [Crossref]  [PubMed]  [PMC]
  5. Belohlavkova S, Kabrnova R, Pospisilova, T, Fuchs M. P34 Food-induced anaphylaxis in children: most common triggers in the Czech Republic. Clin Transl Allergy 2014;4 (1):89. [Crossref]  [PMC]
  6. Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 Kaya, Kan Avoidance of Allergens and Triggers Protection practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-1123. [Crossref]  [PubMed]
  7. Rotella K, Oriel RC. Accidental Reactions to Foods: Frequency, Causes, and Severity. Curr Treat Options Allergy. 2022;9(3):157-168. [Crossref]  [PubMed]  [PMC]
  8. Skypala IJ. Food-Induced Anaphylaxis: Role of Hidden Allergens and Cofactors. Front Immunol. 2019 3;10:673. [Crossref]  [PubMed]  [PMC]
  9. Kraft MT, Scherzer R, Strothman K, Rogers G, Montgomery T, Grayson MH. Establishing Standardized Documentation for Anaphylaxis Treatment in a Tertiary Care Pediatric Allergy Clinic. Pediatr Qual Saf. 2020 15;5(2):e261. [Crossref]  [PubMed]  [PMC]
  10. Kim JS, Sicherer SH. Living with food allergy: allergen avoidance. Pediatr Clin North Am. 2011;58(2):459-70. [Crossref]  [PubMed]
  11. Sicherer SH, Sampson HA. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141(1):41-58. [Crossref]  [PubMed]
  12. Drain KL, Volcheck GW. Preventing and managing drug-induced anaphylaxis. Drug Saf. 2001;24(11):843-53. [Crossref]  [PubMed]
  13. Muraro A, Hoffmann-Sommergruber K, Holzhauser T, Poulsen LK, Gowland MH, Akdis CA, et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI Food Allergy and Anaphylaxis Guidelines. Protecting consumers with food allergies: understanding food consumption, meeting regulations and identifying unmet needs. Allergy. 2014;69(11):1464-72. [Crossref]  [PubMed]
  14. Carter CA, Pistiner M, Wang J, Sharma HP. Food Allergy in Restaurants Work Group Report. J Allergy Clin Immunol Pract. 2020;8(1):70-74. [Crossref]  [PubMed]
  15. Heine RG. Food Allergy Prevention and Treatment by Targeted Nutrition. Ann Nutr Metab. 2018;72 Suppl 3:33-45. [Crossref]  [PubMed]
  16. Cronin C, Salzberg N, Woon Y, Wurttele JT. Primary, secondary and tertiary prevention of food allergy: current practices and future directions. Allergol Immunopathol (Madr). 2024;52(2):32-44. [Crossref]  [PubMed]
  17. Skypala IJ, McKenzie R. Nutritional Issues in Food Allergy. Clin Rev Allergy Immunol. 2019; 57(2):166-178. [Crossref]  [PubMed]
  18. Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, et al. European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. General considerations on rapid desensitization for drug hypersensitivity a consensus statement. Allergy. 2010;65(11):1357-66. [Crossref]  [PubMed]
  19. Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003;68(9):1781-90.
  20. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugué P, Friedmann PS, et al. BSACI. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009;39(1):43-61. [Crossref]  [PubMed]
  21. Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A, Bilo B, et al. Drug allergy passport and other documentation for patients with drug hypersensitivity An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy. 2016;71(11):1533-1539. [Crossref]  [PubMed]
  22. Tanno LK, Gauthier A, Allichon S, Demoly P. Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths. Curr Opin Allergy Clin Immunol. 2022;22(4):215-220. [Crossref]  [PubMed]
  23. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69(4):420-37. [Crossref]  [PubMed]
  24. Bianchi A, Valluzzi R, Crisafulli G, Bottau P, Caimmi S, Franceschini F, et al. Drug-Induced Anaphylaxis in Children. Biomedicines. 2024;12(3):527. [Crossref]  [PubMed]  [PMC]
  25. Castells M. Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations. Front Immunol. 2017;8:1472. [Crossref]  [PubMed]  [PMC]
  26. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol. 2011;127(3 Suppl):S67-73. [Crossref]  [PubMed]
  27. Norton AE, Konvinse K, Phillips EJ, Broyles AD. Antibiotic Allergy in Pediatrics. Pediatrics. 2018;141(5):e20172497. [Crossref]  [PubMed]  [PMC]
  28. Bilò MB, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink JN, Lange J, Jakob T, et al. Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement. Allergy. 2016;71(7):931-43. [Crossref]  [PubMed]
  29. Močnik T, Ličen S, Zidarn M, Prosen M. Exploring Beekeepers' Experiences and Perceptions of Anaphylaxis Risks: A Qualitative Study to Inform Targeted Health Education Programs. Healthcare (Basel). 2024;12(24):2569. [Crossref]  [PubMed]  [PMC]
  30. Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, et al. British Society for Allergy and Clinical Immunology. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 2011;41(9):1201-20. [Crossref]  [PubMed]
  31. Golden DB, Demain J, Freeman T, Graft D, Tankers Kaya, Kan Avoidance of Allergens and Triggers Protection ley M, Tracy J, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28-54. [Crossref]  [PubMed]
  32. Bilò MB, Pravettoni V, Bignardi D, Bonadonna P, Mauro M, Novembre E, et al. Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice. J Investig Allergol Clin Immunol. 2019;29(3):180-205. [Crossref]  [PubMed]
  33. Sahiner UM, Durham SR. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings? Front Immunol. 2019;10:1959. [Crossref]  [PubMed]  [PMC]
  34. Abrams EM, Golden DBK. Approach to Patients with Stinging Insect Allergy. Med Clin North Am. 2020;104(1):129-143. [Crossref]  [PubMed]
  35. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol. 2002;110(2):64-9. [Crossref]  [PubMed]
  36. Turillazzi E, Greco P, Neri M, Pomara C, Riezzo I, Fineschi V. Anaphylactic latex reaction during anaesthesia: the silent culprit in a fatal case. Forensic Sci Int. 2008;179(1):e5-8. [Crossref]  [PubMed]
  37. Mertes PM, Laxenaire MC, Alla F; Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology. 2003;99(3):536-45. [Crossref]  [PubMed]
  38. Dzieża A, Chełmińska M. Latex allergy-cross-reactions. Alergologia Polska-Polish Journal of Allergology. 2014; 1(4):144-149. [Crossref]
  39. Meneses V, Parenti S, Burns H, Adams R. Latex allergy guidelines for people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):601-609. [Crossref]  [PubMed]  [PMC]
  40. Al-Niaimi F, Chiang YZ, Chiang YN, Williams J. Latex allergy: assessment of knowledge, appropriate use of gloves and prevention practice among hospital healthcare workers. Clin Exp Dermatol. 2013;38(1):77-80. [Crossref]  [PubMed]
  41. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg. 2003;97(5):1381-1395. [Crossref]  [PubMed]
  42. Parisi CAS, Kelly KJ, Ansotegui IJ, Gonzalez-Díaz SN, Bilò MB, Cardona V, et al. Update on latex allergy: New insights into an old problem. World Allergy Organ J. 2021;14(8):100569. [Crossref]  [PubMed]  [PMC]
  43. Brans R, Werner S, Obermeyer L, Hansen A, Altenburg C, Nienhaus A. Allergic contact dermatitis to accelerators in rubber gloves marketed as accelerator-free. Contact Dermatitis. 2023;89(1):65-68. [Crossref]  [PubMed]
  44. Tabary M, Araghi F, Nasiri S, Dadkhahfar S. Dealing with skin reactions to gloves during the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2021;42(2):247-248. [Crossref]  [PubMed]  [PMC]
  45. Beierwaltes P, Schoessler S. Latex Safe at School: A Student-Centered Approach. NASN Sch Nurse. 2017;32(6):343-345. [Crossref]  [PubMed]
  46. Nucera E, Aruanno A, Rizzi A, Centrone M. Latex Allergy: Current Status and Future Perspectives. J Asthma Allergy. 2020;13:385-398. [Crossref]  [PubMed]  [PMC]
  47. Rolland JM, O'Hehir RE. Latex allergy: a model for therapy. Clin Exp Allergy. 2008;38(6):898-912. [Crossref]  [PubMed]
  48. Kelly KJ, Wang ML, Klancnik M, Petsonk EL. Prevention of IgE Sensitization to Latex in Health Care Workers After Reduction of Antigen Exposures. J Occup Environ Med. 2011;53(8):934-40. [Crossref]  [PubMed]
  49. Simons FE. Anaphylaxis: Assessment and Management. In: Leung DYM, Szefler SJ, Bonilla FA, Akdis C, Sampson HA (eds). Pediatric Allergy Principles and Practice. 3rd edition. Philadelphia: Saunders Elsevier, 2016:524-36.
  50. Vasconcelos MJ, Delgado L, Silva D. Food-Dependent Exercise-Induced Anaphylaxis. Curr Treat Options Allergy 2018;5:166-180. [Crossref]
  51. Aberumand B., Ellis AK. Exercise-Induced Anaphylaxis. In: Ellis, A. (eds) Anaphylaxis. Springer, Cham; 2020. [Crossref]
  52. M. Geller. "Diagnostic and Therapeutic Approach in Patients with Exercise-Induced Anaphylaxis." Current Treatment Options in Allergy. 2016; 3:181-188. [Crossref]
  53. Pravettoni V, Incorvaia C. Diagnosis of exercise-induced anaphylaxis: current insights. J Asthma Allergy. 2016;9:191-198. [Crossref]
  54. Jiang N, Xu W, Huang H, Hou X, Xiang L. Anaphylaxis in Chinese Children with Pollen Sensitization: Triggers, Clinical Presentation, and Acute Management. Journal of Asthma and Allergy. 2022;15:633 643. [Crossref]  [PubMed]  [PMC]
  55. Li L, Li J, Guan K. Fructose-Bisphosphate Aldolase Mediating Pollen-Food Allergy Syndrome. J Asthma Allergy. 2024;17:1287-1290. [Crossref]  [PubMed]  [PMC]
  56. Carlson G, Coop C. Pollen food allergy syndrome (PFAS): A review of current available literature. Ann Allergy Asthma Immunol. 2019;123(4):359-365. [Crossref]  [PubMed]
  57. Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108-352. [Crossref]  [PubMed]  [PMC]